Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

24. Mai 2022 06:00 ET | Quelle: CareDx, Inc.

CareDx Receives CE Mark for AlloSeq HCT for Use in Hematopoietic Cell Transplantation

SOUTH SAN FRANCISCO, Calif., May 24, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
18. Mai 2022 07:00 ET | Quelle: CareDx, Inc.

CareDx Sponsored ISHLT Innovation Challenge Award Tackles Chronic Lung Allograft Dysfunction

SOUTH SAN FRANCISCO, Calif., May 18, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
17. Mai 2022 07:00 ET | Quelle: CareDx, Inc.

In CareDx-Initiated IP Litigation Against Natera, Natera Now Drops 1 of 2 Patents Originally Asserted Against CareDx

SOUTH SAN FRANCISCO, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
11. Mai 2022 07:00 ET | Quelle: CareDx, Inc.

CareDx Showcases Latest Innovation in Transplantation at European EFI 2022 Conference

SOUTH SAN FRANCISCO, Calif., May 11, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
05. Mai 2022 16:01 ET | Quelle: CareDx, Inc.

CareDx Reports First Quarter 2022 Results

SOUTH SAN FRANCISCO, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
05. Mai 2022 07:00 ET | Quelle: CareDx, Inc.

CareDx Validates Clinical Performance of AlloMap Kidney to Comprehensively Assess Transplant Rejection

SOUTH SAN FRANCISCO, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
28. April 2022 10:45 ET | Quelle: CareDx, Inc.

CareDx Congratulates Board Member Dr. Hannah Valantine on ISHLT Lifetime Achievement Award

SOUTH SAN FRANCISCO, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
28. April 2022 07:00 ET | Quelle: CareDx, Inc.

CareDx Extends Artificial Intelligence Leadership to Heart Transplantation

SOUTH SAN FRANCISCO, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
27. April 2022 16:01 ET | Quelle: CareDx, Inc.

CareDx to Report First Quarter 2022 Financial Results

SOUTH SAN FRANCISCO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
27. April 2022 09:15 ET | Quelle: CareDx, Inc.

International Society for Heart and Lung Transplantation Foundation Selects Reg Seeto as Corporate Chair

SOUTH SAN FRANCISCO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...

Nächste Seite